Fourier transform infrared spectroscopy as well as X-ray diffraction (XRD) were employed to thoroughly study phase transitions taking place during heating–cooling–heating cycle of carbamazepine (CBZ), a well known and commonly used antiepileptic drug. Both techniques revealed cold crystallization taking place during second heating. Moreover, XRD studies for the first time proved the coexistence of CBZ (form I) and iminostilbene (product of the degradation of CBZ) after a heating–cooling cycle. Moving window two-dimensional correlation (MW 2D-COS) spectroscopy and two-dimensional correlation spectroscopy were shown to be effective tools to reveal phase sequences and to provide information about the order of sequential changes of bands’ intensities during each phase transition, respectively.
GrzesiakA.LangM.KimK., et al.“Comparison of the Four Anhydrous Polymorphs of Carbamazepine and the Crystal Structure of Form I”. J. Pharm. Sci. 2003; 92(11): 2260–2271.
2.
BairdJ.A.Van EerdenbrughB.TaylorL.S.“A Classification System to Assess the Crystallization Tendency of Organic Molecules from Undercooled Melts”. J. Pharm. Sci. 2010; 99(9): 3787–3806.
3.
ArlinJ.B.PriceL.S.PriceS.L., et al.“A Strategy for Producing Predicted Polymorphs: Catemeric Carbamazepine Form V”. Chem Commun. 2011; 47(25): 7074–7076.
4.
PintoM.A.L.AmbroziniB.FerreiraA.P.G., et al.“Thermoanalytical Studies of Carbamazepine: Hydration/Dehydration, Thermal Decomposition, and Solid Phase Transitions”. Braz. J. Pharm. Sci. 2014; 50(4): 877–884.
5.
RustichelliC.GamberiniG.FerioliV., et al.“Solid-state Study of Polymorphic Drugs: Carbamazepine”. J. Pharm. Biomed. Anal. 2000; 23(1): 41–54.
LangM.KampfJ.W.MatzgerA.J.“Form IV of Carbamazepine”. J. Pharm. Sci. 2002; 91(4): 1186–1190.
8.
McMahonL.E.TimminsP.WilliamsA., et al.“Characterization of Dihydrates Prepared from Carbamazepine Polymorphs”. J. Pharm. Sci. 1996; 85(10): 1064–1069.
9.
McGregorC.SaundersM.H.BucktonG., et al.“The Use of High-speed Differential Scanning Calorimetry (Hyper-DSC) to Study the Thermal Properties of Carbamazepine Polymorphs”. Thermochim. Acta. 2004; 417(2): 231–237.
10.
DengJ.StaufenbielS.BodmeierR.“Evaluation of a Biphasic In Vitro Dissolution Test for Estimating the Bioavailability of Carbamazepine Polymorphic Forms”. Eur. J. Pharm. Sci. 2017; 105(Suppl. C): 64–70.
11.
HalliwellR.A.BhardwajR.M.BrownC.J., et al.“Spray Drying as a Reliable Route to Produce Metastable Carbamazepine Form IV”. J. Pharm. Sci. 2017; 106(7): 1874–1880.
12.
KobayashiY.ItoS.ItaiS., et al.“Physicochemical Properties and Bioavailability of Carbamazepine Polymorphs and Dihydrate”. Int. J. Pharm. 2000; 193(2): 137–146.
13.
VarmaM.M.Razia BegumS.K.“Formulation, Physicochemical Evaluation, and Dissolution Studies of Carbamazepine Solid Dispersions”. Int. J. Pharm. Sci. Nanotechnol. 2012; 5(3): 1790–1807.
14.
JoshiB.V.PatilV.B.PokharkarV.B.“Compatibility Studies Between Carbamazepine and Tablet Excipients Using Thermal and Non-thermal Methods”. Drug Dev. Ind. Pharm. 2002; 28(6): 687–694.
15.
KrstićM.PopovićM.DobričićV., et al.“Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability”. Molecules. 2015; 20(8): 14684–14698.
16.
AmbrogiV.MarmottiniF.PaganoC.“Amorphous Carbamazepine Stabilization by the Mesoporous Silicate SBA-15”. Microporous Mesoporous Mater. 2013; 177(Suppl. C): 1–7.
17.
NokhodchiA.Al-HamidiH.AntonijevicM.D., et al.“Dissolution and Solid State Behaviours of Carbamazepine-Gluconolactone Solid Dispersion Powders: The Potential Use of Gluconolactone as Dissolution Enhancer”. Chem. Eng. Res. Des. 2015; 100(Suppl. C): 452–466.
18.
MartinsR.M.SiqueiraS.TaconL.A., et al.“Microstructured Ternary Solid Dispersions to Improve Carbamazepine Solubility”. Powder Technol. 2012; 215–216(Suppl. C): 156–165.
19.
DjurisJ.NikolakakisI.IbricS., et al.“Preparation of Carbamazepine–Soluplus Solid Dispersions by Hot-Melt Extrusion, and Prediction of Drug–Polymer Miscibility by Thermodynamic Model Fitting”. Eur. J. Pharm. Biopharm. 2013; 84(1): 228–237.
20.
NokhodchiA.BolourtchianN.DinarvandR.“Dissolution and Mechanical Behaviors of Recrystallized Carbamazepine from Alcohol Solution in the Presence of Additives”. J. Cryst. Growth. 2005; 274(3): 573–584.
21.
StrachanC.HowellS.L.RadesT., et al.“A Theoretical and Spectroscopic Study of Carbamazepine Polymorphs”. J. Raman Spectrosc. 2004; 35(5): 401–408.
22.
SuhasiniM.SailathaE.GunasekaranS., et al.“Molecular Structure and Spectroscopic Characterization of Carbamazepine with Experimental Techniques and DFT Quantum Chemical Calculations”. Spectrochim. Acta., Part A. 2015; 141: 252–262.
23.
DołęgaA.ZielińskiP.M.Osiecka-DrewniakN.“New Insight into Thermodynamical Stability of Carbamazepine”. J. Pharm. Sci. 2019; 108(8): 2654–2660.
24.
NaimaZ.SiroT.Juan-ManuelG.D., et al.“Interactions Between Carbamazepine and Polyethylene Glycol (PEG) 6000: Characterisations of the Physical, Solid Dispersed and Eutectic Mixtures”. Eur. J. Pharm. Sci. 2001; 12(4): 395–404.
25.
NodaI.“Generalized Two-Dimensional Correlation Method Applicable to Infrared, Raman, and Other Types of Spectroscopy”. Appl. Spectrosc. 1993; 47(9): 1329–1336.
26.
NodaI.“Two-Dimensional Infrared (2D IR) Spectroscopy: Theory and Applications”. Appl. Spectrosc. 1990; 44(4): 550–561.
27.
NodaI.“Two-Dimensional Infrared Spectroscopy”. J. Am. Chem. Soc. 1989; 111(21): 8116–8118.
ThomasM.RichardsonH.H.“Two-Dimensional FT-IR Correlation Analysis of the Phase Transitions in a Liquid Crystal, 4′-n-octyl-4-cyanobiphenyl (8CB)”. Vib. Spectrosc. 2000; 24(1): 137–146.
Rodríguez-CarvajalJ.“Recent Advances in Magnetic Structure Determination by Neutron Powder Diffraction”. Phys. B Condens. Matter. 1993; 192(1): 55–69.
32.
D. Lin-Vien, N.B. Colthup, W.G. Fateley, et al. “Compounds Containing the Carbonyl Group”. In: N.B. Colthup, editor. The Handbook of Infrared and Raman Characteristic Frequencies of Organic Molecules. Elsevier Inc., 1991. Chap. 9, Pp. 117–154.
33.
CoatesJ.“Interpretation of Infrared Spectra, A Practical Approach”. In: MeyersR.A. (eds). Encyclopedia of Analytical Chemistry., Chichester, UK: John Wiley and Sons, Ltd., 2000, pp. 10815–10837.
34.
CookA.G.Martínez-FelipeA.BrooksN.J., et al.“New Insights into the Transitional Behaviour of Methyl-6-O-(n-dodecanoyl)-α-D-glucopyranoside Using Variable Temperature FTIR Spectroscopy and X-ray Diffraction”. Liq. Cryst. 2013; 40(12): 1817–1827.
35.
A. Dołęga, E. Juszyńska-Gałązka, A. Deptuch, et al. “Temperature Studies of a Cytotoxic Derivative of Carbamazepine–Iminostilbene”. J. Therm. Anal. Calorim. 2019. Paper Submitted.
36.
ReboulP.J.P.CristauB.SoyferJ.C., et al.“5H-Dibenz[b,f]azépinecarboxamide-5 (Carbamazépine)”. Acta Crystallogr. B. 1981; 37: 1844–1848.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
